{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:13:58Z","timestamp":1792502038284,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.drugalcdep.2015.12.021","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T17:00:21Z","timestamp":1451494821000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"special_numbering":"C","title":["Opioid substitution therapy: Lowering the treatment thresholds"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-078X","authenticated-orcid":false,"given":"Georgios","family":"Kourounis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-2757","authenticated-orcid":false,"given":"Brian David Wensley","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Kyprianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Symeonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva-Melpomeni","family":"Malliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-3036","authenticated-orcid":false,"given":"Lampros","family":"Samartzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09595239800186961","article-title":"The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list","volume":"17","author":"Adamson","year":"1998","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0010","unstructured":"ACMD, Advisory Council on the Misuse of Drugs, Featherstone, L., 2014. Time-Limiting Opioid Substitution Therapy. Featherstone, I. (Ed.). Home Office London"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0015","first-page":"15","article-title":"Should psychosocial intervention be added to pharmacological treatment for opiate abuse\/dependence? An overview of systematic reviews of the literature","volume":"3","author":"Amato","year":"2012","journal-title":"Ital. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"J. Subst. Abuse Treat"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004147.pub3","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/dar.12251","article-title":"Gender differences in access to methadone maintenance therapy in a Canadian setting","author":"Bach","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2010.12.001","article-title":"Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention","volume":"116","author":"Bachireddy","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"Bao","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0050","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1081\/JA-120004176","article-title":"Substitution therapy for heroin addiction","volume":"37","author":"Bell","year":"2002","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1360-0443.2009.02754.x","article-title":"Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands","volume":"105","author":"Blanken","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0060","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0924-977X(10)70001-8","article-title":"Heroin-assisted treatment in the Netherlands: history, findings, and international context","volume":"20","author":"Blanken","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2003.12.009","article-title":"Factors associated with methadone maintenance treatment retention among street-recruited injection drug users","volume":"74","author":"Booth","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.12.002","article-title":"Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses","volume":"147","author":"Bretteville-Jensen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2015.05.033","volume":"153","author":"Chang","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0085","first-page":"19","article-title":"Good practice, good results: maintenance treatment outcomes in France.Heroin Addict","volume":"7","author":"Coppel","year":"2005","journal-title":"Relat. Clin. Probl."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0090","first-page":"57S","article-title":"Opioid replacement therapy","volume":"27","author":"Coppel","year":"2005","journal-title":"Alcoologie et Addictologie"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10550880802544997","article-title":"An 18-year follow-up of patients admitted to methadone treatment for the first time","volume":"28","author":"Davstad","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: a review of the literature","volume":"21","author":"De Maeyer","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"Deering","year":"2011","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0110","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/j.drugalcdep.2014.09.173","article-title":"The impact of opioid substitution therapy on mortality post-release from prison","volume":"146","author":"Degenhardt","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0115","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/2046-4053-3-105","article-title":"The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol","volume":"3","author":"Dennis","year":"2014","journal-title":"Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0125","unstructured":"EMCDDA, European Monitoring Centre for Drugs and Drug Addiction, 2012. HIV In Injecting Drug Users In The EU\/EEA, Following A Reported Increase Of Cases In Greece And Romania. Lisbon, Portugal"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0130","unstructured":"EMCDDA, European Monitoring Centre for Drugs and Drug Addiction, 2012. 2012 Annual Report On The State Of The Drugs Problem In Europe. Lisbon, Portugal. 10.2810\/32306"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0135","unstructured":"EMCDDA, European Monitoring Centre for Drugs and Drug Addiction, 2015. European Drug Report 2015: trends and developments. Lisbon, Portugal. 0.2810\/084165"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0140","unstructured":"EMCDDA, European Monitoring Centre for Drugs and Drug Addiction, 2015. European Drug Report: trends and developments. Lisbon, Portugal"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","volume":"65","author":"Farr\u00e9","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2013.10.011","article-title":"Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: A\\an international systematic review","volume":"134","author":"Feelemyer","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","article-title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance","volume":"35","author":"Gerra","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0165","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0170","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00002030-199910010-00002","article-title":"Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users","volume":"13","author":"Gibson","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2013.05.022","article-title":"Is opioid substitution treatment beneficial if injecting behaviour continues?","volume":"133","author":"Gjersing","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0180","article-title":"Oral substitution treatment for injecting opioid users reduces drug-related behaviours with a high risk of HIV transmission, but has less effect on sex-related risk behaviours","author":"Gowing","year":"2011","journal-title":"Health (Irvine)"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0185","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0899-3467(07)60142-6","article-title":"Writing narrative literature reviews for peer-reviewed journals: secrets of the trade","volume":"5","author":"Green","year":"2006","journal-title":"J. Chiropr. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00023210-200822020-00002","article-title":"Office-based maintenance treatment of opioid dependence","volume":"22","author":"Gunderson","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0200","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","article-title":"The effectiveness of opioid maintenance treatment in prison settings: a systematic review","volume":"107","author":"Hedrich","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11469-007-9084-6","article-title":"Easy-access services in low-threshold opiate agonist maintenance","volume":"6","author":"Hesse","year":"2007","journal-title":"Int. J. Ment. Health Addict."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0210","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1017\/S0033291711000705","article-title":"Characteristics of and trends in subgroups of prisoner suicides in England and Wales","volume":"41","author":"Humber","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0215","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1360-0443.1994.tb03757.x","article-title":"Opiate treatments","volume":"89","author":"Johns","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","author":"Johnson","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society of addiction medicine consensus panel on the use of Buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugalcdep.2014.05.018","article-title":"A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?","volume":"142","author":"Larance","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0240","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.drugalcdep.2014.09.373","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study","volume":"146","author":"Larney","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0245","doi-asserted-by":"crossref","first-page":"e004666","DOI":"10.1136\/bmjopen-2013-004666","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study","volume":"4","author":"Larney","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2014.12.027","article-title":"Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study","volume":"148","author":"Larney","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1360-0443.2011.03618.x","article-title":"Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration","volume":"107","author":"Larney","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0260","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0265","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jadohealth.2006.11.142","article-title":"Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children\u2019s hospital-based outpatient treatment program","volume":"40","author":"Levy","year":"2007","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0270","series-title":"A Cross-Canada Scan Of Methadone Maintenance Treatment Policy Developments","author":"Luce","year":"2011"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0275","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.drugalcdep.2014.09.435","article-title":"Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study","volume":"146","author":"Maher","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0280","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0285","first-page":"587","article-title":"Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence","volume":"10","author":"Mauger","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0290","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","article-title":"The effects of psychosocial services in substance abuse treatment","volume":"269","author":"McLellan","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugpo.2013.03.005","article-title":"Defining a service for people who use drugs as low-threshold: what should be the criteria?","volume":"24","author":"Mofizul Islam","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0300","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsat.2013.09.003","article-title":"Determinants of buprenorphine treatment for opioid dependence","volume":"46","author":"Murphy","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0305","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2015.02.004","article-title":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","volume":"149","author":"Nielsen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0310","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1377\/hlthaff.2012.0846","article-title":"A call for evidence-based medical treatment of opioid dependence in the United States and Canada","volume":"32","author":"Nosyk","year":"2013","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2011.04.003","article-title":"Health related quality of life trajectories of patients in opioid substitution treatment","volume":"118","author":"Nosyk","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0320","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.drugalcdep.2014.09.516","article-title":"The causal effect of opioid substitution treatment on highly active antiretroviral treatment adherence","volume":"146","author":"Nosyk","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.39265.639641.AD","article-title":"Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance","volume":"335","author":"Pilling","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2014.12.008","article-title":"Challenges to implementing opioid substitution therapy in Ukrainian prisons: personnel attitudes toward addiction, treatment, and people with HIV\/AIDS","volume":"148","author":"Polonsky","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0335","first-page":"216","article-title":"Dual diagnosis affects prognosis in patients with drug dependence in integrative care setting","volume":"8","author":"Prodromou","year":"2014","journal-title":"Health Sci. J."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0340","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jsat.2013.10.006","article-title":"From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme","volume":"46","author":"Riksheim","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1027\/0227-5910\/a000205","article-title":"A typology of male prisoners making near-lethal suicide attempts","volume":"34","author":"Rivlin","year":"2013","journal-title":"Crisis"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0350","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0355","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1747-597X-9-32","article-title":"The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study","volume":"9","author":"Shepherd","year":"2014","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000320576","article-title":"Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians","volume":"17","author":"St\u00f6ver","year":"2011","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7517-7-17","article-title":"Drug use and opioid substitution treatment for prisoners","volume":"7","author":"St\u00f6ver","year":"2010","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0370","doi-asserted-by":"crossref","first-page":"g6715","DOI":"10.1136\/bmj.g6715","article-title":"Heroin substitute treatment should not be time limited, says report commissioned by government","volume":"349","author":"Torjesen","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0376-8716(96)01230-6","article-title":"Retention in a low-threshold methadone maintenance program","volume":"41","author":"Torrens","year":"1996","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0380","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.drugalcdep.2013.07.023","article-title":"Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia","volume":"133","author":"Treloar","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0385","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000097935","article-title":"Merits and problems in high-threshold methadone maintenance treatment. Evaluation of medication-assisted rehabilitation in Norway 1998\u20132004","volume":"13","author":"Waal","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0390","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1468-1293.2009.00701.x","article-title":"Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study","volume":"10","author":"Weber","year":"2009","journal-title":"HIV Med."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0395","unstructured":"WHO, 2004. WHO|WHO\/UNODC\/UNAIDS position paper on substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention. World Health Organization Geneva."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0400","unstructured":"WHO Department of Mental Health and Substance Abuse, 2009. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. WHO, Geneva"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0405","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/dar.12143","article-title":"Opioid-related mortality and filled prescriptions for buprenorphine and methadone","volume":"33","author":"Wikner","year":"2014","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0410","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J. Acquired Immune Deficiency Syndr."},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0415","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3109\/10826084.2015.1007696","article-title":"You cannot be in recovery if you are on medication: a concept worth retiring","volume":"50","author":"Wood","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2015.12.021_bib0420","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3399\/bjgp11X613106","article-title":"Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trialarison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial","volume":"61","author":"Wright","year":"2011","journal-title":"Br. J. Gen. Pract."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615018360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615018360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T07:11:11Z","timestamp":1653981071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615018360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":84,"alternative-id":["S0376871615018360"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.021","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid substitution therapy: Lowering the treatment thresholds","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}